carboplatin

(redirected from Carboplatinum)
Also found in: Medical.

carboplatin

[¦kär·bō′plat·ən]
(medicine)
A platinum coordination compound and anticancer agent used for advanced gynecologic malignancies, especially ovarian tumors, and for head and neck cancers and lung cancers.
References in periodicals archive ?
A chemotherapy regimen was started in May 2011 consisting of 6 cycles of carboplatinum (290 mg/day, once in 21 days according to the AUC 4 protocol) and etoposide (100 mg/[m.
Interim data for a study in chemotherapy-naive patients with advanced NSCLC treated with ramucirumab in combination with first-line ALIMTA (pemetrexed for injection)/platinum-based chemotherapy (Abstract #1245) and final data for a study in patients treated with ramucirumab in combination with paclitaxel/ carboplatinum chemotherapy (Abstract#1287) were presented.
TopoTarget also expects to pursue a development programme in ovarian cancer in combination with the standard therapies Carboplatinum and Paclitaxel (the so-called BelCaP combination).
Since ACTH secretion is more prevalent in high-grade neuroendocrine tumors than in carcinoid tumors, we treated our patient with carboplatinum and etoposide, as if she had small cell carcinoma.
My oncologist arranged for me to do six months of carboplatinum and Taxol.
Major groups of traditional ototoxic agents in humans Aminoglycosides Cytotoxic agents Amikacin Bleomycin Dihydrostreptomycin Carboplatinum Gentamicin Cisplatinum Kanamycin Nitrogen mustard Neomycin Vincristine Netilmicin Streptomycin Others Tobramycin Acetylsalicylic acid Arsenicals Loop diuretics Quinine Table 2.
Antitumor activity of a new platinum complex: an experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum.